Pharmaceutical scientists from the National University of Singapore have developed multi-functional synthetic peptide nanonets for relieving inflammation caused by bacterial infection. These nanonets trap bacterial endotoxins and pro-inflammatory cytokines, achieving anti-inflammatory activity through selective binding.
Researchers found that apoE4 poorly binds factor H, a regulatory factor of immunity, leading to amyloid-β oligomerization and neuroinflammation. This could be a potential solution to preventing Alzheimer's disease, with further research needed to find a bridging molecule.
Scientists discovered that inhibiting microRNA-141-3p can reduce chronic inflammation, muscle loss, and bone degradation in aged mice. By blocking this tiny RNA, researchers found improvements in the spleen's immune response, lower levels of pro-inflammatory proteins, and a more youthful profile in bones and muscles.
New research suggests a way to ward off age-related weight gain by stimulating beige fat cells. Beige fat has thermogenic properties that can reduce blood sugar and fatty acids causing heart disease. The study identifies a specific signaling pathway responsible for suppressing beige fat formation in older mice.
Human macrophages use Siglec-14 receptors to recognize and engulf carbon nanotubes, leading to inflammation. The discovery could pave the way for developing safer carbon nanotubes and therapies to prevent inflammatory diseases.
A recent study found that resistance training significantly improved muscle strength and reduced inflammation in older adults with sarcopenia. The research, conducted by Brazilian researchers, also showed that physical exercise can improve sleep quality and reduce chronic inflammation.
Researchers at the University of Virginia Health System have identified a vital contributor to hyperactive immune responses and neuroinflammation in multiple sclerosis. Blocking this regulator alleviated harmful inflammation in lab mice, suggesting a potential therapeutic target for new treatments.
Researchers have discovered a pathway in cells that could be used to reprogram the body's immune system to fight chronic inflammatory and infectious diseases. A molecule derived from glucose, ribulose-5-phosphate, has been found to stop bacteria from growing and dampen inflammatory responses.
Research suggests that avoiding or withdrawing from tough conversations can lead to emotional distress, bad feelings about the relationship, chronic inflammation, and lowered immune function. Couples who exhibit negative communication patterns report fewer positive emotions and slower wound healing.
A new study found that chronic inflammation in lactating mothers with obesity may contribute to low milk production. The researchers analyzed fatty acid and inflammatory marker profiles in blood and breast milk, finding a strong correlation between the two in non-obese mothers but not in those with chronic inflammation.
Researchers at UVA Cancer Center have identified interleukin-1 as a crucial contributor to the development of myelofibrosis, a potentially deadly bone marrow cancer. Targeting this cytokine could prevent myelofibrosis from progressing and spare bone marrow scarring.
A new study suggests that lifestyle choices can help prevent severe COVID-19 by reducing chronic inflammation and regulating the immune system. By adopting healthy habits such as regular exercise, balanced diet, and stress management, individuals can lower their risk of developing severe disease and mitigate post-infection symptoms.
A large randomized clinical trial demonstrated Octagam 10% as an efficacious and well-tolerated treatment option for adult dermatomyositis patients. The study showed improved outcomes in patients with this rare disease, providing a much-needed treatment alternative.
Researchers are studying the interaction between obesity and nitric oxide synthase in triple-negative breast cancer, aiming to develop a new treatment strategy. Another team is investigating the role of NHE6 protein in multiple myeloma resistance to daratumumab treatment, with the goal of improving therapy outcomes for patients.
A study at Washington State University has identified sulfatase-2 as a critical protein driving damage caused by rheumatoid arthritis. The discovery sheds light on molecular processes behind inflammation in the disease and could lead to improved treatments.
A study published in Frontiers in Immunology found that Japanese herbal medicine DKT reduces colitis severity by preventing gut bacteria loss and increasing immune cells. It restores Lactobacillus levels and promotes type 3 innate lymphoid cells, alleviating inflammatory responses.
A world-first study reveals a direct link between low vitamin D and high inflammation, providing a biomarker for those at risk of chronic illnesses. Boosting vitamin D in people with deficiencies may reduce chronic inflammation.
A team from Osaka University developed a silicon-based agent that generates hydrogen when reacting with water, reducing inflammation and symptoms of ulcerative colitis in a mouse model. The study suggests the Si-based agent may be an effective treatment method for this disease.
Researchers developed an AI system that classifies IBDN lesions accurately, displaying image-based diagnostic ability with 64.5% sensitivity and 89.5% specificity. The correct diagnosis rate of the AI system was 79.0, surpassing that of endoscopists, who achieved a 77.8% accuracy rate.
Researchers at Joslin Diabetes Center and Brigham and Women's Hospital found that cold exposure can resolve obesity-induced inflammation while improving insulin sensitivity and glucose tolerance in diet-induced obese mice. Brown adipose tissue is activated to produce anti-inflammatory molecules, including Maresin 2.
Researchers have found a negative correlation between Helicobacter pylori infection and inflammatory bowel disease (IBD) prevalence, suggesting the bacterium may protect against IBD. This is supported by studies showing improved gut microbiota diversity and increased abundance of beneficial bacteria in H. pylori-infected individuals.
Researchers at IRB Barcelona describe a cellular mechanism that coordinates inflammation resolution, with CPEB4 protein playing a crucial role. This regulation involves the balance between pro-inflammatory TTP and anti-inflammatory CPEB4 proteins.
A recent study published in Pharmaceutics suggests that berberine can suppress the proliferation of lung cancer cells, reduce airway inflammation, and modulate genes involved in inflammation. The researchers used liquid crystalline nanoparticles to enhance safety and effectiveness.
A new study suggests that supplementing a diet with Ascidiacea, also known as sea squirts, reverses some main signs of aging in animal models. The researchers found that plasmalogens, vital to body processes, decrease with age and contribute to neurodegenerative diseases like Alzheimer's and Parkinson's.
A new study reveals that recurrent urinary tract infections (UTIs) may be caused by an imbalance in the gut microbiome, which can lead to chronic inflammation and increased risk of future UTIs. Antibiotics given to treat UTIs can disrupt the microbiome, making it easier for disease-causing bacteria to spread.
A new study in mice suggests that forcing the turnover of specific immune cells called microglia can reverse cognitive and behavior problems associated with concussions. The findings provide a potential pathway for developing post-concussion therapies to ward off long-term mental health issues.
Researchers at Universitat Autonoma de Barcelona developed a new treatment that reduces chronic inflammation in multiple sclerosis mice models by administering Maresin-1, a lipid mediator. The substance significantly reduced cytokine levels and protected neurons from demyelination.
High blood pressure can cause long-lasting changes in the structure of vascular smooth muscle cells, stiffening arterial walls and increasing the risk of cerebrovascular disease. Researchers found that a signaling pathway triggered by E–T coupling is involved in this process, leading to inflammation and vascular remodeling.
Researchers have developed a new treatment for chronic inflammation by targeting the ASC protein with nanobodies, which can dissolve harmful molecular complexes and counteract inflammation. The treatment has shown promising results in mouse models, alleviating symptoms of rheumatoid arthritis and gout.
A study at Karolinska Institutet has revealed that a subgroup of innate lymphoid cells (ILCs) can accumulate in the intestinal mucosa of patients with inflammatory bowel disease (IBD). These immature cells can be influenced by gut environment factors, leading to increased cell division and cytokine production.
Researchers at the University of Illinois created quantum dots to visualize macrophages in fat tissue, shedding light on chronic inflammation's role in diseases. The new technology enables accurate cell counting and tracking over time, offering a potential diagnostic tool for insulin resistance and metabolic syndrome.
A clinical trial at UC Davis Health showed that cellular therapy offers promise for patients with late-stage Duchenne muscular dystrophy, stopping deterioration of upper limb and heart functions. The therapy appears to be safe and effective in improving skeletal muscle and cardiac function.
A biodegradable nanoparticle has shown promise in reducing skin and lung scarring in mice with scleroderma. The treatment targets specific immune cells responsible for the disease's chronic inflammation and scarring.
Researchers have identified how IL-36 cytokines instruct proinflammatory CD4+ T cells to accumulate in the inflamed intestine, worsening disease. This discovery offers fresh insights into targeting these proteins as a new therapeutic option for childhood IBD patients.
Researchers at TUM discover that intestinal bacteria interact with Paneth cells in the gut mucus layer, leading to chronic inflammation. This finding may lead to new treatments for IBD.
A recent study by researchers at Case Western Reserve University found that Candida tropicalis fungus can trigger chronic inflammation in the gut microbiome of Crohn's disease patients. This imbalance of fungi and bacteria can create a predisposition to inflammatory bowel disease.
Researchers at Brigham and Women's Hospital discovered a new mediator, 4S, 5S-epoxy-resolvin, that resolves acute inflammation and stimulates tissue regeneration. The study found that this mediator also controls granuloma formation in human leukocytes.
Researchers at Karolinska Institutet discovered that omega-3 fatty acids activate the GPR32 receptor, which reduces inflammation in blood vessels and prevents atherosclerosis. This breakthrough discovery paves the way for new strategies to treat and prevent cardiovascular disease using omega-3 fatty acids.
A study by Weill Cornell Medicine investigators found that antibodies secreted in the gut help control pathogenic forms of gut fungi like Candida albicans. However, patients with Crohn's disease often have impaired antibody function, leading to an overgrowth of harmful fungi.
A new study from Ohio State University suggests that giving social support to others is essential for boosting one's health. The research found that people who were available to provide social support experienced lower inflammation levels, whereas those who only received support did not show the same benefits.
A new study published in Gut Microbes found that exercise intervention reduced pain and lowered inflammatory substances in people with arthritis. Exercise increased levels of cannabis-like substances called endocannabinoids, which may help treat certain conditions.
A study found that D-glyceric acid treatment improved metabolism, blood parameters, and reduced low-grade inflammation in healthy volunteers aged 50-60 years. The compound's activation of mitochondrial metabolism may help interrupt the spiral of persistent systemic inflammation and improve liver function.
Research suggests that obesity triggers inflammation, leading to an increase in myeloid-derived suppressor cells, which break down bone tissue. This can result in gum disease and tooth loss. The study found a significant link between high-fat diets and increased osteoclasts and alveolar bone destruction.
Researchers found that activated neutrophils release proteins like galectin-9, triggering chronic inflammation and oxidative stress. Early screening for HIV is crucial, and finding ways to reduce negative effects of the infection could be key to improving outcomes.
A new study suggests that drinking 100% orange juice significantly reduces interleukin 6, a well-established marker of inflammation, in both healthy and high-risk adults. However, the results did not quite reach statistical significance for two additional inflammatory and oxidative stress markers.
Researchers comprehensively review T-cell responses to respiratory viral infections and chronic obstructive pulmonary disease (COPD), highlighting key characteristics of peptide-reactive T-cells. The review aims to improve understanding of the underlying mechanisms, leading to more effective immune protection and treatment methods.
Pancreatic cells display adaptive response to repeated inflammatory episodes, reprogramming gene expression and epigenetic regulation that cooperates with mutant KRAS to promote tumor formation. Inflammation drives long-term changes in epithelial cells that select for cancer-causing mutations.
A new study published in Science identifies a specific molecule, C1q, that plays a key role in the long-term effects of traumatic brain injury. The researchers found that an antibody treatment could prevent the development of negative outcomes such as sleep disruption and inflammation.
Researchers created a polymer coating that releases Lasioglossin-III, an AMP with broad-spectrum antibacterial activity, targeting specific infectious bacteria and preventing airway complications. The coating demonstrated significant antibacterial activity and prevented bacterial adherence to the tube.
A new study has found that harmful body fat can increase the risk of dementia and stroke, with grey matter atrophy being a key indicator. The research used genetic data from over 336,000 individuals to establish a link between obesity and declining brain health.
Two studies by CU Cancer Center researchers found that chronic inflammation can serve as a key factor in the development of leukemia. Chronic inflammation reduces the fitness of normal cells, hindering their ability to reproduce and creating space for cancer-causing mutations to proliferate. The findings support the theory of adaptive ...
Recent generations show a worrying decline in health compared to previous generations, with poorer physical health, higher levels of unhealthy behaviors, and more depression and anxiety. The researchers found that measures of physical health have worsened from the Baby Boomer generation through Gen X and Gen Y.
Researchers aim to understand how physical health affects mental health in senior cats, with potential implications for early detection and monitoring of chronic inflammation. The study may also provide insights into the relationships between physical and cognitive health in feline patients.
A recent study published in Circulation reveals that immune cells can activate inflammation in the heart by modifying proteins, leading to structural changes and cardiac dysfunction. The researchers have identified a potential target for new treatments, an agent that binds to specific molecules altering cardiac proteins.
Researchers found that propylene glycol and vegetable glycerol cause gut inflammation by breaking down zipper-like junctions between cells. Chronic e-cigarette use can lead to a 'leaky gut,' allowing microbes and molecules to seep out, resulting in chronic inflammation.
Researchers at the Buck Institute have identified chronic inflammation as a driver of NAD+ decline, a key metabolite central to an efficient and healthy metabolism. Senescent cells activate CD38, which degrades NAD+, leading to age-related diseases. Blocking CD38 activity may offer a new target for therapeutic interventions.
A recent study from University of California, Berkeley reveals that disrupted nightly sleep leads to chronic inflammation, which is linked to atherosclerosis and cardiovascular disease. The findings suggest that poor sleep quality can be an important risk factor for heart health, highlighting the need for improved sleep hygiene.
Scientists at UC Berkeley have identified a molecular 'switch' that controls chronic inflammation, which can contribute to devastating diseases. Removing a small bit of molecular matter through deacetylation switches off the immune machinery, potentially reversing age-related conditions.
Researchers have identified chronic inflammation as the primary driver of accelerated aging, leading to a range of diseases including Alzheimer's, atherosclerosis and cancer. This discovery opens up new avenues for early diagnosis, prevention and treatment of these conditions.
Chronic inflammation is linked to 50% of all deaths worldwide, causing heart disease, cancer, diabetes and more. Identifying new biomarkers for early diagnosis and better treatment can help reduce chronic disease and improve health.